Cover Image

Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action

Infantile haemangiomas (IH) are the most common benign tumours of infancy. Although most IH are innocuous and 85-90% regress spontaneously, some may become life‐ or function‐threatening and require immediate treatment. Previous standard therapeutic options include physical measures (laser surgery, c...

Full description

Saved in:
Bibliographic Details
Main Authors: Storch, Caroline Henrike (Author) , Höger, Peter H. (Author)
Format: Article (Journal)
Language:English
Published: 01 August 2010
In: British journal of dermatology
Year: 2010, Volume: 163, Issue: 2, Pages: 269-274
ISSN:1365-2133
DOI:10.1111/j.1365-2133.2010.09848.x
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/j.1365-2133.2010.09848.x
Get full text
Author Notes:C.H. Storch and P.H. Hoeger

MARC

LEADER 00000caa a2200000 c 4500
001 1858112206
003 DE-627
005 20240311125330.0
007 cr uuu---uuuuu
008 230828s2010 xx |||||o 00| ||eng c
024 7 |a 10.1111/j.1365-2133.2010.09848.x  |2 doi 
035 |a (DE-627)1858112206 
035 |a (DE-599)KXP1858112206 
035 |a (OCoLC)1425874208 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Storch, Caroline Henrike  |e VerfasserIn  |0 (DE-588)135835712  |0 (DE-627)572248369  |0 (DE-576)300672349  |4 aut 
245 1 0 |a Propranolol for infantile haemangiomas  |b insights into the molecular mechanisms of action  |c C.H. Storch and P.H. Hoeger 
264 1 |c 01 August 2010 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.08.2023 
520 |a Infantile haemangiomas (IH) are the most common benign tumours of infancy. Although most IH are innocuous and 85-90% regress spontaneously, some may become life‐ or function‐threatening and require immediate treatment. Previous standard therapeutic options include physical measures (laser surgery, cryosurgery) and systemic corticosteroids, in severe cases also vincristine, α‐interferon or cyclophosphamide, all bearing the risk of serious side‐effects. Oral propranolol is a very recent therapeutic option for complicated IH with impressive efficacy and generally good tolerance. The effects of propranolol on IH were discovered by chance, and very little is known about its mechanisms of action in IH. Here we present a summary of current knowledge of how propranolol interferes with endothelial cells, vascular tone, angiogenesis and apoptosis. Early, intermediate and long‐term effects of propranolol on IH can be attributed to three different pharmacological targets. Early effects (brightening of the haemangioma surface within 1-3 days after start of therapy) are attributable to vasoconstriction due to decreased release of nitric oxide. Intermediate effects are due to the blocking of proangiogenic signals (vascular endothelial growth factor, basic fibroblast growth factor, matrix metalloproteinase 2/9) and result in growth arrest. Long‐term effects of propranolol are characterized by induction of apoptosis in proliferating endothelial cells, and result in tumour regression. 
700 1 |a Höger, Peter H.  |e VerfasserIn  |0 (DE-588)129664375  |0 (DE-627)477108911  |0 (DE-576)297774549  |4 aut 
773 0 8 |i Enthalten in  |t British journal of dermatology  |d Oxford : Oxford University Press, 1951  |g 163(2010), 2, Seite 269-274  |h Online-Ressource  |w (DE-627)320433803  |w (DE-600)2004086-6  |w (DE-576)091140285  |x 1365-2133  |7 nnas  |a Propranolol for infantile haemangiomas insights into the molecular mechanisms of action 
773 1 8 |g volume:163  |g year:2010  |g number:2  |g pages:269-274  |g extent:6  |a Propranolol for infantile haemangiomas insights into the molecular mechanisms of action 
856 4 0 |u https://doi.org/10.1111/j.1365-2133.2010.09848.x  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230828 
993 |a Article 
994 |a 2010 
998 |g 135835712  |a Storch, Caroline Henrike  |m 135835712:Storch, Caroline Henrike  |p 1  |x j 
999 |a KXP-PPN1858112206  |e 4370569923 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"roleDisplay":"VerfasserIn","display":"Storch, Caroline Henrike","role":"aut","family":"Storch","given":"Caroline Henrike"},{"family":"Höger","given":"Peter H.","roleDisplay":"VerfasserIn","display":"Höger, Peter H.","role":"aut"}],"title":[{"title_sort":"Propranolol for infantile haemangiomas","subtitle":"insights into the molecular mechanisms of action","title":"Propranolol for infantile haemangiomas"}],"language":["eng"],"recId":"1858112206","note":["Gesehen am 28.08.2023"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["C.H. Storch and P.H. Hoeger"]},"id":{"eki":["1858112206"],"doi":["10.1111/j.1365-2133.2010.09848.x"]},"origin":[{"dateIssuedKey":"2010","dateIssuedDisp":"01 August 2010"}],"relHost":[{"title":[{"title_sort":"British journal of dermatology","subtitle":"BJD ; the journal of the British Association of Dermatologists","title":"British journal of dermatology"}],"pubHistory":["Volume 63, issue 1 (January 1951)-"],"part":{"volume":"163","text":"163(2010), 2, Seite 269-274","extent":"6","year":"2010","issue":"2","pages":"269-274"},"titleAlt":[{"title":"BJD"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Propranolol for infantile haemangiomas insights into the molecular mechanisms of actionBritish journal of dermatology","note":["Gesehen am 03.07.25"],"language":["eng"],"corporate":[{"role":"isb","display":"British Association of Dermatologists","roleDisplay":"Herausgebendes Organ"}],"recId":"320433803","origin":[{"publisherPlace":"Oxford ; Oxford [u.a.] ; Oxford [u.a.] ; Oxford","dateIssuedDisp":"1951-","dateIssuedKey":"1951","publisher":"Oxford University Press ; Blackwell Science ; Blackwell ; Wiley-Blackwell"}],"id":{"doi":["10.1111/(ISSN)1365-2133"],"eki":["320433803"],"zdb":["2004086-6"],"issn":["1365-2133"]},"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"6 S."}]} 
SRT |a STORCHCAROPROPRANOLO0120 

Similar Items